Filter News

Cantel Medical To Hold Conference Call To Discuss Results For Its First Quarter Ended October 31, 2015

Published: Dec 04, 2015

LITTLE FALLS, N.J., Dec. 3, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMN) will release the results for its first quarter ended October 31, 2015 on Thursday, December 10 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.

To participate in the conference call, dial (877) 407-8033 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, December 10, 2015 through midnight on February 10, 2016 by dialing (877) 660-6853 and using conference ID # 13625708

The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=174554.  A replay of the webcast will be available for 90 days on PrecisionIR and via the investor relations page of the Cantel web site.

About Cantel Medical Corp.

Cantel Medical (NYSE: CMN) is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products.  Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at www.cantelmedical.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-hold-conference-call-to-discuss-results-for-its-first-quarter-ended-october-31-2015-300187693.html

SOURCE Cantel Medical Corp.



Back to news